One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).
Alessandro BeneduceGiuseppe FerranteAlfonso IelasiCarlo A PivatoMauro ChiaritoAlberto CappellettiLuca BaldettiValeria MagniEugenio PratiStefania FalconeAdele PierriStefano De MartiniMatteo MontorfanoRosario ParisiDavid RutiglianoNicola LocuratoloAngelo AnzuiniMaurizio TespiliAlberto MargonatoAlberto BenassiCarlo BriguoriBernhard ReimersFranco FabbiocchiAntonio BartorelliAntonio ColomboCosmo GodinoPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
This study is the first all-comers evaluation of BP-SES in DM patients. Our findings show that DM patients, mostly those with ITDM, still represent a vulnerable population and experience significantly higher rate of TLF. Overall BP-SES efficacy is considerable, although not statistically significant higher rate of TLR is still present in DM compared to non-DM patients.